GSTM1 and GSTT1 null genotype frequencies in 300 healthy individuals from urban Venezuela.
This cross-sectional descriptive study evaluated the prevalence of GSTM1 and GSTT1 null genotypes among 300 healthy unrelated individuals residing in an urban area of Venezuela. The intervention or exposure involved genotyping for these specific null polymorphisms, with regional and global reference data serving as the comparator context.
The primary outcome measured the frequency of these genetic variants. The study reported a GSTM1 null genotype frequency of 38.67%, a GSTT1 null genotype frequency of 32.67%, and a double null genotype frequency of 6.00%. No secondary outcomes were reported, and no adverse events, serious adverse events, discontinuations, or tolerability data were collected or reported.
Key limitations include the cross-sectional design, which precludes causal inference, and the lack of reported p-values or confidence intervals for the observed frequencies. The study provides an updated genetic baseline for the urban cohort and a descriptive framework for future toxicogenomic research and personalized medicine applications, though it does not inform clinical management of specific conditions.